Navigating the complexities of pre-filled syringe manufacturing

Download the whitepaper to gain insights that can help inform your PFS manufacturing approach

As demand for pre-filled syringes (PFS) continues to accelerate, driven by the rise of biologics, chronic disease therapies and patient-centric delivery, drug developers face a growing set of technical and operational challenges in bringing these products to market.

This whitepaper explores the complexities of PFS manufacturing, from managing sensitive formulations to minimizing high-value product loss. It also examines strategies for delivering precision in fill-finish operations while maintaining compliance with evolving regulatory standards.

Drawing on Pfizer CentreOne’s deep sterile injectable (SI) expertise, this whitepaper outlines practical strategies and established methods designed to help address complexity and support the reliable, scalable production of high-quality PFS therapies.